Clinical Research & Data, Complete Revascularization, Safety & Efficacy, AMI Cardiogenic Shock, Protected PCI

Your Destination for TCT 2020 Event Resources

TCT Connect highlighted the benefits of a more complete revascularization with Impella heart pumps in high-risk PCI patients and the value of Impella protocol-based treatment for survival and native heart recovery in cardiogenic shock patients. Throughout the virtual conference, leading physicians such as Junya Ako, MD, Francesco Burzotta, MD, Cindy Grines, MD, Jeffrey Moses, MD, Bill O’Neill, MD, Duane Pinto, MD, MPH, and Giuseppe Tarantini, MD, PhD, presented clinical data and best practice protocols.

In the video below, Chuck Simonton, MD, and Seth Bilazarian, MD, present an overview of TCT 2020 highlights, including new PROTECT III study data that demonstrates reduced rates of MACCE when Impella is used to achieve a more complete revascularization in a single setting for high-risk PCI patients.

 
 

Achieving >70% AMI-CS Survival: Best Practices From Around the World

Achieving >70% survival in AMICS is reproducible with best practice protocols. This symposium will provide the key learnings and the supporting clinical evidence of the best practices from USA, Japan and Europe.

Hot Topics

 

Efficacy and Safety of ALL Impella Use in Japanese Patients With Drug-Resistant Acute HF: Insight From Japan J-PVAD Study

Junya Ako, MD

 

Importance of Timing and Impact of Extensive Revascularization on Long-term Survival in Cardiogenic Shock: Insights From European Multicenter Studies

Giuseppe Tarantini, MD, PhD

 

Closing Summation, RECOVER III, and Intro to RECOVER IV

William O'Neill, MD

 

Restore EF Study Demonstrates Impella-Supported High-Risk PCI Improves Left Ventricular Ejection Fraction

Intermediate-term left ventricular function following non-emergent Impella Protected PCI: RESTORE EF study with Mitul Patel, MD

View more resources

NPS-1069